We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Therapy for Recurrent Pediatric Brain Cancer Enters Clinical Testing

News   Apr 28, 2020 | Original story from Baylor College of Medicine

 
New Therapy for Recurrent Pediatric Brain Cancer Enters Clinical Testing
 
 
Advertisement
 

RELATED ARTICLES

Gut Microbiota Composition Indicates Efficacy of Drugs in Inflammatory Bowel Diseases

News

Researchers investigated whether any predictors associated with infliximab therapy could be identified in the gut microbiota.

READ MORE

Antiviral Enzymes Convert Pre-Leukemia Stem Cells Into Leukemia

News

In response to inflammation, two enzymes called APOBEC3C and ADAR1 work together to trigger the transformation of pre-cancer stem cells to cancer stem cells in leukemia.

READ MORE

Using a 90-Day Vaginal Ring To Prevent HIV and Pregnancy

News

A vaginal ring containing an antiretroviral drug called dapivirine and the contraceptive hormone levonorgestrel delivered sustained levels of each drug when used continuously for 90 days according to results of a Phase 1 study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE